HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DSM expands R&D efforts

This article was originally published in The Rose Sheet

Executive Summary

DSM Nutritional Products expands its North American research and development facilities with the Nutrition Innovation Center at its Parsippany, N.J. headquarters. The supplier says Feb. 8 the new center will "bring together DSM's extensive laboratory capabilities for the thriving beverage, bakery, dairy, savory, dietary supplement and personal-care market sectors." DSM's personal-care ingredient roster includes vitamins, UV filters, emulsifiers and carotenoids. The firm expects to open the center in 2011

You may also be interested in...



DSM Sharpens Personal-Care Focus With New Products, Growth Initiatives

Recognizing the current opportunity in personal care, Royal DSM N.V. is growing that branch of its business with an updated product portfolio, a new corporate image and international expansion initiatives.

Roche Continues To Make The Case For Gantenerumab In Alzheimer’s Disease

The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.

Brinavess' US Review: EU Postmarket Data Unlikely To Save Troubled AFib Drug

Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug;  FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.

UsernamePublicRestriction

Register

RS016742

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel